Literature DB >> 15814671

Antinuclear antigen B cells that down-regulate surface B cell receptor during development to mature, follicular phenotype do not display features of anergy in vitro.

Xiaohe Liu1, Tim Manser.   

Abstract

We previously demonstrated that B cells expressing a transgenic BCR with "dual reactivity" for the hapten arsonate and nuclear autoantigens efficiently complete development to follicular phenotype and stably reside in follicles in vivo. These B cells express very low levels of surface IgM and IgD, suggesting that they avoid central deletion and peripheral anergy by reducing their avidity for autoantigen via surface BCR (sBCR) down-regulation. Since a variety of states of B cell anergy have been previously described, a thorough examination of the functional capabilities of these B cells was required to test this hypothesis. In this study, we show that surface Ig cross-linking induces amounts of proximal BCR signaling in these B cells commensurate with their reduced sBCR levels. Functionally, however, they are comparable to nonautoreactive B cells in cell cycle progression, up-regulation of activation and costimulatory molecules, and Ab-forming cell differentiation when treated with a variety of stimuli in vitro. In addition, these B cells can efficiently process and present Ag and are capable of undergoing cognate interaction with naive TCR-transgenic T cells, resulting in robust IL-2 production. Together, these data reveal a lack of intrinsic anergy involving any known mechanism, supporting the idea that this type of antinuclear Ag B cell becomes indifferent to cognate autoantigen by down-regulating sBCR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814671     DOI: 10.4049/jimmunol.174.8.4505

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Influence of Fas on the regulation of the response of an anti-nuclear antigen B cell clonotype to foreign antigen.

Authors:  Boris Alabyev; Raja Vuyyuru; Tim Manser
Journal:  Int Immunol       Date:  2008-08-08       Impact factor: 4.823

Review 2.  The riddle of the dual expression of IgM and IgD.

Authors:  Roland Geisberger; Marinus Lamers; Gernot Achatz
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

3.  Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.

Authors:  Amedeo Cappione; Jennifer H Anolik; Aimee Pugh-Bernard; Jennifer Barnard; Paul Dutcher; Gregg Silverman; Iñaki Sanz
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

Review 4.  Innate pathways to B-cell activation and tolerance.

Authors:  Steve P Crampton; Elisaveta Voynova; Silvia Bolland
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

5.  The lupus-prone NZM2410/NZW strain-derived Sle1b sublocus alters the germinal center checkpoint in female mice in a B cell-intrinsic manner.

Authors:  Eric B Wong; Tahsin N Khan; Chandra Mohan; Ziaur S M Rahman
Journal:  J Immunol       Date:  2012-11-09       Impact factor: 5.422

Review 6.  Role of inhibitory signaling in peripheral B cell tolerance.

Authors:  Andrew Getahun
Journal:  Immunol Rev       Date:  2022-02-06       Impact factor: 12.988

Review 7.  B cells and immunological tolerance.

Authors:  Nataly Manjarrez-Orduño; Tâm D Quách; Iñaki Sanz
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

8.  The regulation of autoreactive B cells during innate immune responses.

Authors:  Barbara J Vilen; Jennifer A Rutan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

9.  The lupus susceptibility locus Sle1 breaches peripheral B cell tolerance at the antibody-forming cell and germinal center checkpoints.

Authors:  Raja Vuyyuru; Chandra Mohan; Tim Manser; Ziaur S M Rahman
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

10.  Functionally responsive self-reactive B cells of low affinity express reduced levels of surface IgM.

Authors:  Greg A Kirchenbaum; James B St Clair; Thiago Detanico; Katja Aviszus; Lawrence J Wysocki
Journal:  Eur J Immunol       Date:  2014-01-20       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.